Accelerated Radiotherapy More Effective For Treating Head And Neck Cancer (p 933)September 17, 2003Danish research published in this week's issue of THE LANCET provides strong evidence that the shortening of radiotherapy treatment time has definitive benefits for people being treated for head and neck cancer. There is debate among oncologists about the optimum treatment time for patients given radiotherapy for head and neck cancer. Jens Overgaard from Aarhus University Hospital, Denmark, and colleagues investigated whether the shortening of treatment time by use of six instead of five radiotherapy fractions per week improved patients' tumour response. In a randomised controlled trial between 1992 and 1997, around 1400 patients with head and neck cancer were allocated to receive either five or six fractions of radiotherapy per week (spread over 46 and 39 days, respectively); the total radiation dose was the same for both groups. Five-year tumour control was 10% better in patients given six fractions per week (70% tumour control) compared with those given radiotherapy five times a week (60%). Accelerated radiotherapy helped voice preservation in patients with laryngeal cancer; it also was associated with a small increase in disease-specific survival compared with patients given five fractions per week, although acute morbidity was more common among those given accelerated radiotherapy. Jens Overgaard comments: "Although all patients in the accelerated treatment arm did better, some did better than others, and we are currently trying to identify those groups where the benefit is largest. It appears to be linked to two factors - a high degree of expression of epidermal growth factor receptor (EGFR) and a good differentiation of the tumour." * the results will be presented next week at ECCO 12 - the European Cancer Conference2, taking place in Copenhagen, Denmark. Lancet |
|||||||||||||||||||||
| Related Cancer Current Events and Cancer News Articles U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU) Presidency, for establishing a transatlantic task force to address antibiotic resistance, an urgent and growing problem that threatens patient safety and public health worldwide. 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. SNM applauds House action to build medical isotopes reactor in the US SNM applauds the U.S. House of Representatives for its passage of H.R. 3276-the American Medical Isotopes Production Act of 2009. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. New finding suggests prostate biopsy is not always necessary Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy. PET imaging response a prognostic factor after thoracic radiation therapy for lung cancer A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented by researchers at Thomas Jefferson University Hospital at the 51st ASTRO Annual Meeting. Scientists visualize how bacteria talk to one another Using imaging mass spectrometry, researchers at the University of California, San Diego have developed tools that will enable scientists to visualize how different cell populations of cells communicate. Findings show nanomedicine promising for treating spinal cord injuries Researchers at Purdue University have discovered a new approach for repairing damaged nerve fibers in spinal cord injuries using nano-spheres that could be injected into the blood shortly after an accident. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. Breast density associated with increased risk of cancer recurrence A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||